ELYM Insider Trading

Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $49,952,816.64
Insider Selling (Last 12 Months): $346,976.45

Eliem Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Eliem Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eliem Therapeutics Share Price & Price History

Current Price: $6.86
Price Change: Price Increase of +0.05 (0.73%)
As of 07/3/2024 01:00 AM ET

This chart shows the closing price history over time for ELYM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Eliem Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/3/2024Valerie MorissetEVPSell50,000$6.76$338,000.00462,956View SEC Filing Icon  
6/27/2024Ra Capital Management, L.P.DirectorBuy13,008,546$3.84$49,952,816.6423,521,757View SEC Filing Icon  
6/20/2024Emily PimblettCAOSell1,245$7.21$8,976.453,755View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Eliem Therapeutics (NASDAQ:ELYM)

69.76% of Eliem Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELYM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Eliem Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/23/2024BML Capital Management LLC2,193,742$6.01M4.0%+0.6%7.914%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC2,180,000$5.89M4.4%+12.5%7.907%Search for SEC Filing on Google Icon
1/26/2024Cerity Partners LLC13,821$37K0.0%N/A0.050%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC121,110$0.32M0.1%-75.5%0.447%Search for SEC Filing on Google Icon
10/23/2023BML Capital Management LLC1,938,263$5.10M4.7%+22.4%7.155%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC494,089$1.38M0.4%+1.7%1.830%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC810,593$2.27M0.0%+20.3%3.003%Search for SEC Filing on Google Icon
7/24/2023BML Capital Management LLC1,583,170$4.43M4.0%-4.5%5.866%Search for SEC Filing on Google Icon
4/14/2023BML Capital Management LLC1,658,170$4.81M4.2%-9.1%6.148%Search for SEC Filing on Google Icon
2/14/2023Driehaus Capital Management LLC551,942$2.03M0.0%+58.3%2.077%Search for SEC Filing on Google Icon
2/13/2023BML Capital Management LLC1,825,134$6.70M6.4%N/A6.869%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can25,244$93K0.0%N/A0.095%Search for SEC Filing on Google Icon
11/8/2022Atom Investors LP67,074$0.22M0.1%+154.9%0.252%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC402,088$1.30M0.4%-43.6%1.513%Search for SEC Filing on Google Icon
8/16/2022Parkwood LLC67,202$67K0.2%+63.4%0.253%Search for SEC Filing on Google Icon
7/25/2022Silverarc Capital Management LLC713,009$2.15M0.7%+707.7%2.684%Search for SEC Filing on Google Icon
5/12/2022Monashee Investment Management LLC227,201$1.91M0.6%-24.3%0.855%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd15,874$0.13M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP373,368$3.91M0.1%-3.6%1.406%Search for SEC Filing on Google Icon
2/15/2022Samlyn Capital LLC1,703,546$17.82M0.2%+1.3%6.417%Search for SEC Filing on Google Icon
2/11/2022Parkwood LLC30,609$0.32M0.1%N/A0.115%Search for SEC Filing on Google Icon
2/7/2022Monashee Investment Management LLC300,000$3.14M0.8%-1.7%1.130%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund3,359$35K0.0%N/A0.013%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC2,880$30K0.0%N/A0.011%Search for SEC Filing on Google Icon
12/29/2021Hudson Bay Capital Management LP100,000$1.80M0.0%N/A0.377%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al287,294$5.17M0.0%N/A1.082%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.13,150,849$236.45M3.3%N/A49.536%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$1.35M0.0%N/A0.283%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC76,904$1.38M0.0%N/A0.290%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.165,952$2.98M0.0%N/A0.625%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.332,126$5.97M0.0%N/A1.251%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC305,233$5.49M1.0%N/A1.150%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG4,063$73K0.0%N/A0.015%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Eliem Therapeutics logo
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Read More on Eliem Therapeutics

Today's Range

Now: $6.86
Low: $6.69
High: $6.87

50 Day Range

MA: $7.82
Low: $3.39
High: $10.20

52 Week Range

Now: $6.86
Low: $2.35
High: $11.55

Volume

85,421 shs

Average Volume

176,402 shs

Market Capitalization

$204.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Eliem Therapeutics?

Eliem Therapeutics' top insider shareholders include:
  1. Ra Capital Management, LP (Director)
  2. Valerie Morisset (EVP)
  3. Emily Pimblett (CAO)
Learn More about top insider investors at Eliem Therapeutics.